MarketInOut Stock Screener Log In | Sign Up

Revelation Biosciences Inc Wt

NASDAQ • Healthcare • Biotechnology • Quote as of 10/28/2026 10:11
Revelation Biosciences Inc Wt stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization0.0355 mln
Float0.44 mln
Earnings Date11/06/2026

Piotroski F-Score

2 / 9
Weak

Relative Strength

90 / 100
Top performer

Debt / Equity

0.07
Debt-free

ROE

-115
Deeply negative

ROA

-93.68
Deeply negative

Business Description

Revelation Biosciences is a San Diego-based drug development company focused on treating conditions caused by imbalanced immune responses. Its core technology, Gemini, is designed to regulate the body's inflammatory system and serves as the foundation for two pipeline treatments targeting acute and chronic kidney disease. The company was founded in 2019 and rebranded under its current name in January 2022.

Key Fundamentals

EPS-4.77
ROE-115
ROIC-974
ROA-93.68
EBITDA, mln-11.24
EV / EBITDA0.79

Quote Details

Last 0.0056
Change 0 (0%)
Open 0.0056
Volume 1,350
Turnover 7.56
Average Volume 31,764

Financial Ratios

Leverage Ratio1.24
Current Ratio6.21
Price / Book0.00
Debt / Equity0.07

Financial Strength

Piotroski F-Score 2 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -34.12% 1 / 100   
1 Month -38.45% 7 / 100   
2 Months -52.54% 8 / 100   
6 Months -24.32% 25 / 100   
1 Year -38.46% 25 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog